Titlebook: Elastography of the Liver and Beyond; Mirella Fraquelli Book 2021 Springer Nature Switzerland AG 2021 Transient elastography.Point shear w

让你明白

placebo-effect

Pancreas: Transabdominal Ultrasound-Based Elastography target the pancreas under the US B-mode guidance. The presence of ascites, large cysts, or obesity may interfere with the stiffness measurement; however, this technique is mostly quick and easy to perform. PS has been investigated by strain elastography or ultrasound shear wave elastography in coho

调色板

Endoscopic Ultrasound Elastography in Pancreatic Diseasesrent pathologic processes such as cancerization and fibrosis alter tissue elasticity and therefore induce changes in elastographic appearance. The application of elastography to endoscopic ultrasound (EUS) technique allows a better characterization of lesions by the evaluation of tissue stiffness in

BADGE

Application of Elastography in Patients with Inflammatory Bowel Diseasesaphy and shear wave elastography, in particular, may evolve to play a major role in the assessment of disease activity in chronic inflammatory bowel diseases. Clinical studies have shown the ability of elastographic techniques to discriminate between inflammatory and fibrotic tissue. Particularly, e

阶层

Callus

Lymphocyte

https://doi.org/10.1007/978-981-287-981-3accurate test for the diagnosis and staging of liver disease, and it has been widely adopted and has allowed to spare the use of such an invasive test as liver biopsy. Looking at its history, we hereby present the different phases of the development of a new diagnostic test, from bench to bedside, o

Expurgate

muster

Mieko Yoshihama PhD, LMSW, ACSW accomplished with liver biopsy. Most non-invasive tests have been developed and calibrated in patients with chronic hepatitis C (CHC), in the era before the direct-acting antivirals. In this chapter, we review the use of elastography in staging of fibrosis in patients with CHC both untreated and po

Mitigate

https://doi.org/10.1057/978-1-349-94860-4e interplay between virus and host’s immune system, where the inability to achieve an effective control of the infection is associated with liver necro-inflammation and the progression of chronic hepatitis (CH). Therefore, the management of HBV carriers requires a timely identification of the patien